Quantcast

Long Term Remissions Studies Show Diabetes Relapse in Gastric Bypass Patients, Calling For Continued Fasting Blood Glucose Testing

December 1, 2012

Published findings recently released by the Group Health Research Institute show that over a third of patients who suffered from type-2 diabetes mellitus would enter full relapse within five years passing from their surgeries. Doctors urge the importance of preventative treatment over the need for such invasive surgeries.

Seattle, WA (PRWEB) November 30, 2012

A detailed retrospective report has been comprised by the Group Health Research Institute in hopes of examining the probability of patients reported to have full-blown diabetes remission through extensive fasting blood glucose testing. The initial intent of the surgery is to regain control of the glycemic index, without the need for additional medications to assist. The study included patients from three integrated systems of health care in the United States. With a reported 4,434 patients who have had the surgery entering remission, the incremental chances appeared to increase over time. 68,2 % (95 % confidence interval [CI], 66 and 70 %) of these cases went into remission within five years, whereas 35.1 % (95 % CI, 32 and 38 %) of the patients’ type-2 diabetes returned within the same amount of time. A full explanation of the findings can be found at http://www.ncbi.nlm.nih.gov/pubmed/23161525

FastingBloodGlucose.net characterizes diabetes mellitus as a continual hyperglycemia which arises from any combination of risk factors and as the most common form of blood sugar regulatory failure disease at this time. This inability to regulate glucose within the blood stream can be accurately tested by refraining from ingestion for at least eight hours and measuring the levels of glucose within the blood at that time. Unlike other diabetes tests, the fasting plasma glucose can be taken no matter the age or amount of physical activity in the patient’s regimen. This allows previous gastric bypass patients the ability to monitor their glucose levels after surgery upon monthly visits to see if additional medications and treatment are required for preventing relapse of the disease.

Dr. Edward Livingston, a bariatric surgeon, was quoted as saying “Short-term outcomes are impressive-patients undergoing bariatric surgery maintain more weight loss compared with diet and exercise. Comorbidities such as type 2 diabetes can be reversed. But long-term consequences remain uncertain. Issues such as whether weight loss is maintained and the long-term effects of altering nutrient absorption remain unresolved.” in Self Magazine.

About Fasting Blood Glucose

Fasting Blood Glucose is one of the leading destinations for all looking to keep up to date with current advances in the detection, prevention and treatment of diabetes. Determined to become the internet’s #1 source for diabetes related news, contributors are dedicated to providing accurate information as to the least-invasive methods of testing, such as FPG(Fasting Plasma Glucose). For more information, contact FastingBloodGlucose.net

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/11/prweb10189049.htm


Source: prweb



comments powered by Disqus